Regulatory & Legal

In a routine filing with major implications, Albion Crown VCT directors reinvest dividends, signaling deep faith in the VCT model as tax rules evolve.

Henri Beaufour’s passing transfers a major Ipsen stake to a charity. We analyze the governance safeguards and what it means when philanthropy enters the boardroom.

A monumental $31.5 billion contract tasks Peraton with replacing the FAA's aging air traffic control system. Can it succeed where others have failed?

As Airbus doubles down in China, the partnership between Paris and Beijing reveals a pragmatic model balancing deep economic ties with a bold geopolitical vision.

The landmark partnership validates China's biotech prowess and injects Takeda's pipeline with next-gen cancer therapies, signaling a major industry shift.

With a clear FDA path for its breakthrough drug, Praxis is set to disrupt the stagnant, multi-billion-dollar essential tremor market.

After its DMD drug trial sent shares soaring over 370%, Capricor Therapeutics is raising $75M. A look at the high-stakes strategy to fund a breakthrough.

Immunome is using strategic stock grants to lure top talent. We analyze why this move is critical for its pipeline and what it means for investors.

With $15M in new funding and seasoned mining execs on board, Getty Copper is now debt-free and poised to unlock the potential of its vast copper assets.

Promising Phase 3 data reveals a novel, organ-sparing laser therapy for a rare cancer, signaling a potential paradigm shift away from radical surgery.

Beyond the hype of air taxis, one Oregon firm is electrifying aviation's workhorses, from firefighting helicopters to military vehicles, in extreme conditions.

As REV Group preps its Q4 report, all eyes are on whether its booming specialty vehicle segment can offset volatility in the recreational vehicle market.

Westinghouse's new robotics deal with PROMATION is more than a partnership; it’s a key move in building a Canadian supply chain for a global nuclear revival.

An agency wins top awards for its storytelling, but the real prize is finding homes for 11,000 kids. Can narrative change the fate of a system in crisis?

SoftBank's move to delist French robotics firm BALYO offers a premium to shareholders but signals a larger consolidation in the automated logistics space.

OC Waste & Recycling's free compost giveaway is more than a local perk; it's a key part of California's ambitious plan to transform waste management.

A last-minute regulatory filing by Balyasny Asset Management pulls back the curtain on the multi-billion-dollar battle for Spectris, a key health tech enabler.

Beyond the award, we explore Diebold Nixdorf's ESG data, the rise of corporate responsibility rankings, and why sustainability is now core business strategy.

A regulatory filing reveals Balyasny Asset Management's strategic trading in Just Group as the stock hits a 52-week high during a takeover.

Stricter safety rules are pressuring pharmacies. Discover how advanced software is helping them navigate complex regulations and protect patients from harm.